NAVAMEDIC ASA |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 34.7 NOK | -1.70% |
|
+2.06% | -5.45% |
| 05-06 | Navamedic Rolls Out Erectile Dysfunction Drug in Sweden | MT |
| 04-30 | Navamedic ASA Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NAVAMEDIC ASA | Other Pharmaceuticals | -1.70% | +2.06% | -5.45% | -10.10% | +88.59% | 57.58M |  |  |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- NAVA Stock
- Charts Navamedic ASA
- Comparison Chart
